Lynparza and Lorazepam drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Lynparza (olaparib) and Lorazepam (lorazepam). Common drug interactions include restlessness among females and pleural effusion among males.
The phase IV clinical study analyzes what interactions people have when they take Lynparza and Lorazepam. It is created by eHealthMe based on reports of 63 people who take the same drugs from the FDA, and is updated regularly.
What is Lynparza?
Lynparza has active ingredients of olaparib. eHealthMe is studying from 12,322 Lynparza users. Check the latest studies of Lynparza.
What is Lorazepam?
Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
63 people who take Lynparza and Lorazepam together, and have interactions are studied.

What are the common drug interactions of Lynparza and Lorazepam, by gender? *:
female:
- Restlessness (not able to rest)
- Salivary hypersecretion (excess saliva secretion)
- Sleep disorder
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Tinnitus (a ringing in the ears)
- Balance disorder
- Blood pressure increased
- Cardiomegaly (increased size of heart than normal)
- Chest pain
- Dehydration (dryness resulting from the removal of water)
male:
- Pleural effusion (water on the lungs)
- Pneumonia
- Dyspnoea (difficult or laboured respiration)
- Fatigue (feeling of tiredness)
- Gastroenteritis (inflammation of stomach and intestine)
- Heart rate increased
- Hospitalisation
- Intervertebral disc disorder (spinal disc disorder)
- Malignant neoplasm progression (cancer tumour came back)
- Myalgia (muscle pain)
What are the common drug interactions of Lynparza and Lorazepam, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Nausea (feeling of having an urge to vomit)
- Vomiting
- Back pain
- Death
- Diarrhoea
- Fatigue (feeling of tiredness)
- Abdominal pain upper
- Apathy
- Arthralgia (joint pain)
- Asthenia (weakness)
50-59:
- Contusion (a type of hematoma of tissue in which capillaries)
- Dizziness
- Fall
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Hallucination (an experience involving the perception of something not present)
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Urticaria (rash of round, red welts on the skin that itch intensely)
- Death
- Diarrhoea
- Rash
60+:
- Fatigue (feeling of tiredness)
- Nausea (feeling of having an urge to vomit)
- Diarrhoea
- Malignant neoplasm progression (cancer tumour came back)
- Myalgia (muscle pain)
- Asthenia (weakness)
- Muscle spasms (muscle contraction)
- Abdominal discomfort
- Fall
- Metastases to liver (cancer spreads to liver)
What are the existing conditions these people have? *
- Ovarian Cancer (cancer of ovary): 32 people, 50.79%
- Sleep Disorder: 10 people, 15.87%
- Nausea (feeling of having an urge to vomit): 8 people, 12.70%
- Pain: 6 people, 9.52%
- High Blood Cholesterol: 6 people, 9.52%
- Constipation: 5 people, 7.94%
- Neuropathy Peripheral (surface nerve damage): 4 people, 6.35%
- Malignant Peritoneal Neoplasm (cancer tumour of peritoneum): 4 people, 6.35%
- Insomnia (sleeplessness): 4 people, 6.35%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 6.35%
* Approximation only. Some reports may have incomplete information.
Do you take Lynparza and Lorazepam?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Lynparza and Lorazepam:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lynparza:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Lorazepam:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lynparza and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lorazepam and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on olaparib and lorazepam (the active ingredients of Lynparza and Lorazepam, respectively), and Lynparza and Lorazepam (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cardizem Cd cause Hair Loss? - a second ago
- Could Naloxone cause Acute Respiratory Failure? - 10 seconds ago
- Drug interactions of Humalog and Polysporin - 20 seconds ago
- Cipro and Common Peroneal Nerve Dysfunction for Women aged 50-59 - 21 seconds ago
- Cipro and Peroneal Nerve Palsy for Women aged 50-59 - 21 seconds ago
- Cipro and Peroneal Nerve Injury for Women aged 50-59 - 21 seconds ago
- Cipro and Neuropathy - Common Peroneal Nerve for Women aged 50-59 - 22 seconds ago
- Erythromycin and Losartan drug interactions for women aged 50-59 - 23 seconds ago
- Omega-3 and Glucosamine drug interactions for women aged 60+ - 24 seconds ago
- Drug interactions of Delzicol and Tramadol - 26 seconds ago